News

Deal Announcements

ABT Molecular Adds Venture Capital Debt

Monday, August 25, 2014 5:30:00 AM PDT | VentureDeal
   Louisville, Tennessee  --  Medical imaging company ABT Molecular Imaging has received $750,000 in venture capital debt funding, according to an SEC regulatory filing.

ABT has developed a platform that produces unit doses of molecular imaging drugs for PET scans.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

ABT is still seeking $510,000 in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1